David A. Rubenstein

3.6k total citations
86 papers, 1.8k citations indexed

About

David A. Rubenstein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, David A. Rubenstein has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 15 papers in Hematology. Recurrent topics in David A. Rubenstein's work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Platelet Disorders and Treatments (13 papers) and Coronary Interventions and Diagnostics (11 papers). David A. Rubenstein is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Platelet Disorders and Treatments (13 papers) and Coronary Interventions and Diagnostics (11 papers). David A. Rubenstein collaborates with scholars based in United States, India and United Kingdom. David A. Rubenstein's co-authors include Wei Yin, J. Radziuk, John Dupré, Timothy J. McDonald, Berhane Ghebrehiwet, Jolyon Jesty, Danny Bluestein, Hongbing Lu, Li Chen and Mary D. Frame and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

David A. Rubenstein

84 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Rubenstein United States 24 387 338 325 255 201 86 1.8k
Horst‐Dieter Lemke Germany 25 156 0.4× 170 0.5× 472 1.5× 341 1.3× 130 0.6× 58 2.2k
Hitoshi Okazaki Japan 23 284 0.7× 235 0.7× 192 0.6× 383 1.5× 400 2.0× 106 2.1k
Jing Jing Wang Australia 27 228 0.6× 160 0.5× 335 1.0× 553 2.2× 265 1.3× 84 2.5k
S. Blaise France 20 485 1.3× 170 0.5× 470 1.4× 104 0.4× 115 0.6× 123 1.8k
Arnon Blum Israel 24 336 0.9× 510 1.5× 267 0.8× 407 1.6× 139 0.7× 88 2.2k
Edith Tzeng United States 20 645 1.7× 440 1.3× 428 1.3× 830 3.3× 457 2.3× 63 2.7k
Yang Yu China 29 263 0.7× 369 1.1× 608 1.9× 509 2.0× 291 1.4× 162 2.7k
Lin Zhao China 29 215 0.6× 381 1.1× 323 1.0× 1.2k 4.5× 350 1.7× 166 2.9k
Harriet W. Hopf United States 29 204 0.5× 429 1.3× 1.4k 4.2× 261 1.0× 323 1.6× 78 3.6k
Huimin Yan United States 25 165 0.4× 476 1.4× 190 0.6× 278 1.1× 219 1.1× 81 1.9k

Countries citing papers authored by David A. Rubenstein

Since Specialization
Citations

This map shows the geographic impact of David A. Rubenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Rubenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Rubenstein more than expected).

Fields of papers citing papers by David A. Rubenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Rubenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Rubenstein. The network helps show where David A. Rubenstein may publish in the future.

Co-authorship network of co-authors of David A. Rubenstein

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Rubenstein. A scholar is included among the top collaborators of David A. Rubenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Rubenstein. David A. Rubenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Polonio, Carolina Manganeli, et al.. (2025). The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation. Nature Reviews Drug Discovery. 24(8). 610–630. 18 indexed citations
3.
Sadhasivam, Balaji, Vengatesh Ganapathy, Pawan Acharya, et al.. (2024). Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in Head and Neck Cancer Cells. International Journal of Molecular Sciences. 25(2). 1032–1032. 3 indexed citations
4.
Rubenstein, David A., et al.. (2021). Development of 3D Printed Electrospun Scaffolds for the Fabrication of Porous Scaffolds for Vascular Applications. 3D Printing and Additive Manufacturing. 9(5). 380–388. 5 indexed citations
5.
Joseph, Kusumam, et al.. (2021). gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema. Inflammation. 45(1). 116–128. 4 indexed citations
6.
Yin, Wei, et al.. (2021). SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts. Clinical Immunology. 227. 108733–108733. 12 indexed citations
7.
Savitt, Anne G., Wei Yin, Huiquan Duan, et al.. (2021). SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems. Frontiers in Immunology. 12. 767347–767347. 38 indexed citations
8.
Rubenstein, David A. & Wei Yin. (2018). Platelet‐Activation Mechanisms and Vascular Remodeling. Comprehensive physiology. 8(3). 1117–1156. 59 indexed citations
9.
Rubenstein, David A. & Wei Yin. (2018). Platelet‐Activation Mechanisms and Vascular Remodeling. Comprehensive physiology. 8(3). 1117–1156. 6 indexed citations
11.
Rubenstein, David A., et al.. (2016). Platelets modulate endothelial cell response to dynamic shear stress through PECAM-1. Thrombosis Research. 150. 44–50. 25 indexed citations
12.
Rubenstein, David A., et al.. (2015). Tobacco and e-cigarette products initiate Kupffer cell inflammatory responses. Molecular Immunology. 67(2). 652–660. 52 indexed citations
13.
Yin, Wei, et al.. (2015). Altered Flow Changes Thrombin Generation Rate of Circulating Platelets. Annals of Biomedical Engineering. 43(12). 2827–2837. 7 indexed citations
14.
Rubenstein, David A. & Wei Yin. (2014). Hypergravity and Hypobaric Hypoxic Conditions Promote Endothelial Cell and Platelet Activation. High Altitude Medicine & Biology. 15(3). 396–405. 6 indexed citations
15.
Yin, Wei, et al.. (2012). A Biocompatible Flow Chamber to Study the Hemodynamic Performance of Prosthetic Heart Valves. ASAIO Journal. 58(5). 470–480. 5 indexed citations
16.
Rubenstein, David A., et al.. (2012). Characterization of the Physical Properties and Biocompatibility of Polybenzoxazine-Based Aerogels for Use as a Novel Hard-Tissue Scaffold. Journal of Biomaterials Science Polymer Edition. 23(9). 1171–1184. 24 indexed citations
17.
Rubenstein, David A., et al.. (2011). Effects of physiologically relevant dynamic shear stress on platelet complement activation. Platelets. 22(8). 602–610. 23 indexed citations
18.
Rubenstein, David A., et al.. (2007). Bioassay Chamber for Angiogenesis with Perfused Explanted Arteries and Electrospun Scaffolding. Microcirculation. 14(7). 723–737. 34 indexed citations
19.
Bahou, Wadie F., L E Scudder, David A. Rubenstein, & Jolyon Jesty. (2004). A Shear-restricted Pathway of Platelet Procoagulant Activity Is Regulated by IQGAP1. Journal of Biological Chemistry. 279(21). 22571–22577. 25 indexed citations
20.
Rubenstein, David A., et al.. (1995). Pedal ectrodactyly: A biomechanical approach to management. The Journal of Foot & Ankle Surgery. 34(2). 215–219. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026